GLP-1 Market
LLY $1184.63 ▼ -0.0% NVO $38.31 ▼ -1.0% PFE $28.72 • 0.0% VKTX $31.81 ▼ -3.7% KLRA $10.99 ▼ -1.2% GPCR $32.69 ▼ -6.8% RHHBY $52.25 ▼ -2.1%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Biological check-up

Company
Centre Hospitalier Universitaire Dijon
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
2 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

2 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 30, 2026

Find a Clinical Trial Near Me

See recruiting studies for Biological check-up and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT05305794

    Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes"

    Not yet reported Centre Hospitalier Universitaire Dijon 76 participants Est. completion 2028-08 1 site Added to GLP-1
    Other conditions: Double Diabetes
    View official trial listing →
  • Recruiting NCT NCT06613555

    Retinal Microvascularization in OCT-angiography and Systemic Diseases

    Centre Hospitalier Universitaire Dijon 5000 participants Est. completion 2044-06 1 site
    Other conditions: Systemic Vascular Damage
    View official trial listing →
  • Status unknown NCT NCT01323218

    Sleep Apnea Syndrome and Vitamin D

    Not yet reported University Hospital, Clermont-Ferrand 80 participants Est. completion 2012-06 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Terminated NCT NCT03264820

    Study of the Reproducibility of Laser Measurement in the Detection of Digital Obstructive Arterial Disease (DOAD)

    Not yet reported Rennes University Hospital 17 participants Est. completion 2019-04-10 1 site Stand-alone
    Other conditions: Vascular Diseases
    View official trial listing →
  • Completed NCT NCT04828928

    Neuropathy in Patients Monitored for Wild-type TTR Cardiac Amyloidosis (Non-mutated)

    Not yet reported University Hospital, Bordeaux 65 participants Est. completion 2023-03-31 3 sites Stand-alone
    Other conditions: Wild-type Amyloid Cardiopathy
    View official trial listing →
  • Completed NCT NCT04937621

    Study of Arrhythmia and ECG Abnormalities in Patients With COVID-19

    University Hospital, Bordeaux 196 participants Est. completion 2020-12-31 1 site
    Other conditions: Arrhythmia, SARS-CoV-2 Infection
    View official trial listing →
  • Completed NCT NCT05927363

    Impact on Physical Activity of Coronary Patients in Phase 3 of a Therapeutic Consolidation Educational Program Involving a "Patient Partner" Associated With a Healthcare Professional.

    Not yet reported Centre Hospitalier Universitaire de Nīmes 84 participants Est. completion 2025-12-09 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT06137898

    The Benefits of Dietary and Micro-nutritional Management for Well-being at Work

    Larena SAS 200 participants Est. completion 2025-12-31 1 site
    Other conditions: Well-Being, Psychological
    View official trial listing →
  • Not yet recruiting NCT NCT06944873

    Metabolic Reprogramming of Monocytes in Inflammatory Flares of Inflammatory Bowel Diseases

    University Hospital, Grenoble 30 participants Est. completion 2028-07-31 1 site
    Other conditions: Inflammatory Bowel Disease (IBD)
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.